FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC´s shares more than halved from post-pandemic highs due to leverage, de-stocking trends, and patent issues, making it a huge underperformer. The struggles are real, but the company guides for a recovery in the second half of the year, while divesting some assets to create liquidity. While management does not have credibility on its side, the risk-reward looks compelling, certainly if improvements are delivered upon.
FMC is selling its Global Specialty Solutions business to Envu for $350 million to focus on its core business.
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Investors need to pay close attention to FMC Corp (FMC) stock based on the movements in the options market lately.
FMC Corp (FMC) gains on efforts to strengthening its product portfolio and cost-reduction actions amid challenges from weaker demand due to inventory de-stocking.
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
FMC believes that Azugro and Ezanya herbicides will help growers control weeds that are resistant to other herbicides, resulting in a healthier harvest.
I believe FMC stock is depressed and is poised for a turnaround in the 2H of 2024. The company has faced significant headwinds from the global crop protection inventory destocking phenomena damaging company performance, a scathing short-seller report, and a historically levered B/S. Despite these headwinds, FMC has tailwinds that begin in the 2H of FY 2024 that should improve company performance and cash generation.
FMC will use Optibrium's Cerella and StarDrop technologies to expand its internal research and development.